LR Pharma
ActiveSummary
LR Pharma has been active since 2024 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €17,908 and a net result of €15,741. Its solvency ranks better than 49% of 9,585 sector peers (NACE 82, financial year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).
History
Acts, filings and financial milestones
2025
19-12
NBB filing
Annual accounts filed
financial year 2025 · micro format
2024
25-09
Gazette deed
IncorporationAppointment: RECOUR Leonie Marguerite (director) · Bank account · Founding capital5 facts ▸
Gazette deed
Incorporation
Appointment: RECOUR Leonie Marguerite (director) · Bank account · Founding capital5 facts ▸
- Incorporation, 20-09-2024
- Bank account, “Crelan, vennootschap in oprichting” (deed in Dutch)
- Other provision, 18-09-2024
- Director appointment, RECOUR Leonie Marguerite (director (not named in the articles))
- Founding capital, €3,000
Gazette deedNBB filing
1 of 1 deed read